MiraDx test for radiation therapy toxicity validated in new study
A new study has confirmed that a molecular diagnostic test developed by MiraDx can predict the side effects of radiation therapy in prostate cancer patients prior to treatment. The post MiraDx test for radiation therapy toxicity validated in new study appeared first on Medical Device Network.
A new study has confirmed that a molecular diagnostic test developed by MiraDx can predict the side effects of radiation therapy in prostate cancer patients prior to treatment.
The post MiraDx test for radiation therapy toxicity validated in new study appeared first on Medical Device Network.
